Corrigendum: Afatinib for Advanced Non-small Cell Lung Cancer in a Case With an Uncommon Epidermal Growth Factor Receptor Mutation (G719A) Identified in the Cerebrospinal Fluid.

Front Oncol

Zhuhai SanMed Biotech Ltd., Zhuhai, China.

Published: September 2019

[This corrects the article DOI: 10.3389/fonc.2019.00628.].

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798028	PMC
http://dx.doi.org/10.3389/fonc.2019.00938	DOI Listing

Publication Analysis

corrigendum afatinib

afatinib advanced

advanced non-small

non-small cell

cell lung

lung cancer

cancer case

case uncommon

uncommon epidermal

epidermal growth

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!